Please ensure Javascript is enabled for purposes of website accessibility
Kody Kester

Kody Kester


Recent articles

A masked woman plays a slot machine at a casino

2 Stocks to Buy With Dividends Yielding More Than 4%

These two triple-net-lease REITs offer safe and reliable yields to dividend investors at fair valuations.

A team of surgeons performs a surgery

2 Top Healthcare Stocks to Buy Right Now

Both of these stocks are healthcare leaders and they're trading at reasonable valuations.

A patient meets with their doctor for an appointment

2 Embarrassingly Cheap Dividend Stocks to Buy

The market has written off these two high-quality stocks, but both could complement an income investor's portfolio.

Senior woman meets with doctor for appointment

2 Best Biotech Stocks to Buy in September

The market's caution when it comes to the healthcare sector presents a buying opportunity for these two solid businesses.


2 Dividend Stocks That Will Pay You for Life

Are you looking for steady dividends to stand the test of time? Here are a couple of stocks to consider buying.

Doctor conducts physical exam on elderly woman

How Keytruda's Latest Approval in China Boosts Merck

Keytruda received its second regulatory approval in China for the treatment of esophageal cancer.

Doctor performs physical exam on patient

These Promising Clinical Results Could Be Huge for Amgen Investors

New data from the phase 3 trial of tezepelumab bodes well for the drug candidate becoming a significant revenue producer in the near future.

Nurse administers COVID vaccine to elderly man

Could This Be Pfizer's Next Blockbuster Vaccine?

Pfizer isn't resting on the laurels of its COVID vaccine success.

Young man meets with doctor

Could This Game-Changing FDA Approval Mean Profit for Johnson & Johnson Shareholders?

Johnson & Johnson's Invega Hafyera was approved by the FDA as the first and only twice-yearly injectable treatment for schizophrenia.

Patient meets with doctor for an appointment

Could This Label Expansion Be a Blockbuster for AbbVie's Shareholders?

The EC's approval of Rinvoq for moderate to severe eczema is another step in the right direction for the company.

A patient presents to their doctor for an appointment

Merck Investors Have Reason to Cheer This Label Expansion

The biopharma company announced that it received two more approved indications for Keytruda in Japan.

Man reads book while sitting on sofa

Williams-Sonoma Knows How to Treat Its Shareholders

This specialty retailer handed out its second dividend hike of the year and authorized a new, larger share repurchase program.

A senior patient meets with their doctor for an appointment

AstraZeneca Enters Another Major Market With This Indication

The pharma giant recently received approval to market Forxiga as a treatment for chronic kidney disease patients in Japan.

Team of surgeons performing operation

Is This Medical-Device-Making Dividend Aristocrat a Buy?

Medtronic met analysts' consensus revenue estimate and exceeded earnings forecasts in the first quarter of its fiscal 2022.

Waitress takes a couple's orders

Is This Monthly Dividend Payer a Buy?

Realty Income is one of the steadiest publicly traded REITs, and growth should accelerate with record acquisitions set for this year.

An elderly woman meets with doctor

Does the Pullback in This Pharma Stock Create a Buying Opportunity?

Amgen continues to face the headwind of patient visits that are lower than before the pandemic.

A medical professional meets with a patient for an appointment

Here's What This Label Expansion Could Mean for Eli Lilly Investors

The pharmaceutical company's type 2 diabetes drug Jardiance was recently approved by the FDA for another indication.

Patient meets with doctor for appointment

Could These Clinical Results Mean Profit for AbbVie Shareholders?

The pharma stock announced strong phase 3 results for atogepant in the preventive treatment of episodic migraine.

Young doctor meets with senior woman

This Potential Indication Could Mean Profit for Eli Lilly Investors

Eli Lilly updated investors on its ongoing phase 3 trials to treat patients who have moderate to severe eczema with a new drug.

A veterinarian performs a check up on a dog

Should You Buy the Dip in This Pet Insurer?

Trupanion reported a mixed second quarter with a revenue beat and an EPS miss.